Differential cytotoxicity of dopamine and H2O2 in a human neuroblastoma divided cell line transfected with α-synuclein and its familial Parkinson's disease-linked mutants

被引:39
作者
Wersinger, C [1 ]
Sidhu, A [1 ]
机构
[1] Georgetown Univ, Dept Pediat, Washington, DC 20007 USA
关键词
Parkinson's disease; synuclemopathies; neurodegeneration; alpha-synuclein; dopamine; H2O2; Lewy bodies;
D O I
10.1016/S0304-3940(03)00212-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
a-Synuclein accumulates in Lewy bodies and two missense mutations, A30P and A53T, have been linked to familial Parkinson's disease. Neither the normal function of a-synuclein nor the pathomechanism of alpha-synuclein-induced neuropathy are known. SK-N-MC neuroblastoma cells were transiently transfected with either wt alpha-synuclein, or its mutants, and their abilities to protect against oxidative stress were assessed. At low expression levels (1 mug cDNA/10(5) cells), all three synuclein variants were devoid of any effect on dopamine-induced cytotoxicity and nitrite production, whereas at higher expression (5 mug cDNA/l 05 cells), the variants enhanced dopamine-mediated effects. Low levels of wt a-synuclein blocked H2O2-induced cytotoxicity and nitrite production, a protective effect that was partly decreased upon higher expression. Both A30P and A53T increased in a dose-dependent manner H2O2-induced nitrite production and cell death. These results show an absence of protective effects for the A30P/A53T mutants, and a differential cytoprotective role of alpha-synuclein against oxidants, which varies according to expression levels. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:124 / 128
页数:5
相关论文
共 20 条
[1]   The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease [J].
Clayton, DF ;
George, JM .
TRENDS IN NEUROSCIENCES, 1998, 21 (06) :249-254
[2]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[3]   Wild-type but not Parkinson's disease-related Ala-53 → Thr mutant α-synuclein protects neuronal cells from apoptotic stimuli [J].
da Costa, CA ;
Ancolio, K ;
Checler, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :24065-24069
[4]   EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE CAUSES DELAYED NEUROTOXICITY IN PRIMARY MIXED NEURONAL-GLIAL CORTICAL CULTURES [J].
DAWSON, VL ;
BRAHMBHATT, HP ;
MONG, JA ;
DAWSON, TM .
NEUROPHARMACOLOGY, 1994, 33 (11) :1425-1430
[5]   Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein [J].
Giasson, BI ;
Duda, JE ;
Quinn, SM ;
Zhang, B ;
Trojanowski, JQ ;
Lee, VMY .
NEURON, 2002, 34 (04) :521-533
[6]   α-synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells [J].
Hashimoto, M ;
Hsu, LJ ;
Rockenstein, E ;
Takenouchi, T ;
Mallory, M ;
Masliah, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :11465-11472
[7]   The synuclein family [J].
Lavedan, C .
GENOME RESEARCH, 1998, 8 (09) :871-880
[8]   Effect of the overexpression of wild-type or mutant α-synuclein on cell susceptibility to insult [J].
Lee, M ;
Hyun, DH ;
Halliwell, B ;
Jenner, P .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (04) :998-1009
[9]   Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice [J].
Lee, MK ;
Stirling, W ;
Xu, YQ ;
Xu, XY ;
Qui, D ;
Mandir, AS ;
Dawson, TM ;
Copeland, NG ;
Jenkins, NA ;
Price, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) :8968-8973
[10]   Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter [J].
Matsuoka, Y ;
Vila, M ;
Lincoln, S ;
McCormack, A ;
Picciano, M ;
LaFrancois, J ;
Yu, X ;
Dickson, D ;
Langston, WJ ;
McGowan, E ;
Farrer, M ;
Hardy, J ;
Duff, K ;
Przedborski, S ;
Di Monte, DA .
NEUROBIOLOGY OF DISEASE, 2001, 8 (03) :535-539